Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,059 public trials 1,846 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Active, not recruiting

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT06162572

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Henry Ford Health Detroit, Michigan, United States
  • Gabrail Cancer Center Canton, Ohio, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Instituto Médico Especializado Alexander Fleming Buenos Aires, Argentina
View all 56 locations
View Trial Details
Active, not recruiting

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

NCT02955290

Conditions
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Squamous Non-Small Cell Lung Carcinoma, Bronchial Neoplasms, +29 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • St. Francis Hospital Roslyn, New York, United States
  • Good Samaritan Hospital West Islip, New York, United States
View Trial Details
Active, not recruiting

A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

NCT04280081

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiated Hospital Of Guangzhou Medical University Guangzhou, Guangdong, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View all 13 locations
View Trial Details
Active, not recruiting

Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)

NCT02453282

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Yuma, Arizona, United States
  • Research Site Bakersfield, California, United States
View all 196 locations
View Trial Details

Related conditions